EBIRIOS - Exenatide and Basal Insulins Use in the Real Setting: an Italian Observational Study in Patients With Type 2 Diabetes and Secondary Failure of Oral Antihyperglycemic Treatment.
Phase of Trial: Phase IV
Latest Information Update: 18 Jul 2014
At a glance
- Drugs Exenatide; Insulin; Insulin detemir; Insulin glargine; Insulin neutral protamine lispro
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- Acronyms EBIRIOS
- Sponsors AstraZeneca
- 27 Nov 2013 Status changed from active, no longer recruiting to completed, according to ClinicalTrials.gov record.
- 07 Mar 2012 Planned end date changed from 1 Mar 2012 to 1 May 2012 as reported by ClinicalTrials.gov.
- 16 May 2011 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.